156 related articles for article (PubMed ID: 25755323)
21. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
[TBL] [Abstract][Full Text] [Related]
22. Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment.
Boga S; Jain D; Schilsky ML
Pediatr Gastroenterol Hepatol Nutr; 2015 Sep; 18(3):202-8. PubMed ID: 26473142
[TBL] [Abstract][Full Text] [Related]
23. The Multiple Facets of ABCB4 (MDR3) Deficiency.
Sundaram SS; Sokol RJ
Curr Treat Options Gastroenterol; 2007 Dec; 10(6):495-503. PubMed ID: 18221610
[TBL] [Abstract][Full Text] [Related]
24. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature.
Delaunay JL; Durand-Schneider AM; Delautier D; Rada A; Gautherot J; Jacquemin E; Aït-Slimane T; Maurice M
Hepatology; 2009 Apr; 49(4):1218-27. PubMed ID: 19185004
[TBL] [Abstract][Full Text] [Related]
25. Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(8):G670-6. PubMed ID: 24481602
[TBL] [Abstract][Full Text] [Related]
26. Heterozygous ABCB4 mutations in children with cholestatic liver disease.
Gordo-Gilart R; Hierro L; Andueza S; Muñoz-Bartolo G; López C; Díaz C; Jara P; Álvarez L
Liver Int; 2016 Feb; 36(2):258-67. PubMed ID: 26153658
[TBL] [Abstract][Full Text] [Related]
27.
Cheng N; Qin YJ; Zhang Q; Li H
World J Clin Cases; 2023 Jul; 11(20):4903-4911. PubMed ID: 37584002
[TBL] [Abstract][Full Text] [Related]
28. Combined Mutations of Canalicular Transporter Proteins Causing Low Phospholipid-Associated Cholelithiasis and Transient Neonatal Cholestasis in an Infant.
Lourembam R; Malik R; Bolia R
JPGN Rep; 2021 May; 2(2):e080. PubMed ID: 37207060
[TBL] [Abstract][Full Text] [Related]
29. Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of
Zhu H; Wang S; Li L; Geng W; Wan X; Hua R; Wang D; Gao P
Front Pediatr; 2022; 10():1012825. PubMed ID: 36330364
[TBL] [Abstract][Full Text] [Related]
30. Late diagnosed Wilson disease with hepatic and neurological manifestations.
Honma Y; Harada M; Sato M; Katsuki Y; Hiura M; Shibata M; Narita R; Harada R; Abe S; Tabaru A; Tajiri N; Shimajiri S
Hepatol Res; 2011 Mar; 41(3):270-6. PubMed ID: 21338455
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.
Andress EJ; Nicolaou M; Romero MR; Naik S; Dixon PH; Williamson C; Linton KJ
Hepatology; 2014 May; 59(5):1921-31. PubMed ID: 24806754
[TBL] [Abstract][Full Text] [Related]
32. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
[TBL] [Abstract][Full Text] [Related]
33. A novel heterozygous deletion in ABCB4 gene in a Chinese family with intrahepatic cholestasis of pregnancy, neonatal hyperbilirubinemia, and cholelithiasis: Case reports and literature review.
Zheng Y; Rao Q; Han Y; He J
Mol Genet Genomic Med; 2024 Jan; 12(1):e2291. PubMed ID: 37787087
[TBL] [Abstract][Full Text] [Related]
34. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH
World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319
[TBL] [Abstract][Full Text] [Related]
35. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
[TBL] [Abstract][Full Text] [Related]
36. A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report.
Bai J; Li L; Liu H; Liu S; Bai L; Ning H; Song W; Zou H; Wang X; Chen Y; Zheng S; Duan Z
Ann Transl Med; 2021 Mar; 9(5):426. PubMed ID: 33842647
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
[TBL] [Abstract][Full Text] [Related]
38. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
Wu Z; Zhang S; Zhang L; Li M
Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542
[TBL] [Abstract][Full Text] [Related]
39. Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
de Vries E; Mazzetti M; Takkenberg B; Mostafavi N; Bikker H; Marzioni M; de Veer R; van der Meer A; Doukas M; Verheij J; Beuers U
Liver Int; 2020 Dec; 40(12):3042-3050. PubMed ID: 32893960
[TBL] [Abstract][Full Text] [Related]
40. Genetic Analysis of
Wang HH; Portincasa P; Liu M; Wang DQ
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
